Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Stock Price Down 8.3

published 31.07.2020 15:26

Image of article 'Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Stock Price Down 8.3'

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States.

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) last released its quarterly earnings data on Wednesday, May 6th.

Separately, Zacks Investment Research lowered Ampio Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, June 9th.

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) dropped 8.3% on Wednesday .

by Daniel Rudford from theolympiareport.com

Free awesomeness straight to your inbox!

Sign up now for this free newsletter to receive hand picked content, covering topics like Lifestyle, Business & Technology.

Free Newsletter Sign up now!

..or jump directly to the latest posts!